Farxiga vs. Glimepiride

See how Farxiga and Glimepiride compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Farxiga is an SGLT2 inhibitor that lowers blood sugar and also protects the heart and kidneys, while glimepiride is an older sulfonylurea used only for blood sugar control.

  • Glimepiride carries a real risk of hypoglycemia because it pushes the pancreas to release more insulin, while Farxiga's blood sugar effect does not typically cause lows on its own.

  • Farxiga costs far more out of pocket than glimepiride, which is one of the least expensive diabetes pills available.

Farxiga vs. Glimepiride Drug Summary

Farxiga

Farxiga (dapagliflozin) is an SGLT2 inhibitor that lowers blood sugar by causing the kidneys to remove excess glucose through urine. It is FDA-approved for type 2 diabetes, heart failure, and chronic kidney disease, and is taken as one tablet by mouth once a day.

Glimepiride

Glimepiride is a sulfonylurea that lowers blood sugar by stimulating the pancreas to release more insulin. It is FDA-approved only for type 2 diabetes as an add-on to diet and exercise, and is taken as one tablet by mouth once a day, with the dose slowly increased over time.

Farxiga vs. Glimepiride Side Effects

Farxiga

Most common
Nasopharyngitis (6.3%)
Back pain (4.2%)
Increased urination (3.8%)
Dyslipidemia (2.9%)

Glimepiride

Most common
Hypoglycemia (>5%)
Dizziness (>5%)
Asthenia (>5%)
Headache (>5%)

Farxiga vs. Glimepiride Dosage

Farxiga

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg once daily At the start
Maximum dose 10 mg once daily If needed
Dose changes 1 increase As tolerated

Glimepiride

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg once daily At the start
Maximum dose 8 mg once daily If needed
Dose changes 3 increases As tolerated

Farxiga vs. Glimepiride Indications

Farxiga

Farxiga is approved to control blood sugar in adults and children 10 and older with type 2 diabetes. It also carries separate approvals for reducing heart failure hospitalization, treating heart failure across ejection fraction types, and slowing chronic kidney disease progression.

  • Type 2 diabetes blood sugar control (ages 10+)

  • Heart failure treatment across ejection fraction types

  • Chronic kidney disease progression and cardiovascular risk

  • Reduces risk of heart failure hospitalization in at-risk patients

Glimepiride

Glimepiride is approved only to control blood sugar in adults with type 2 diabetes, used alongside diet and exercise. It carries no heart failure or kidney disease approval, unlike newer diabetes drug classes, and is not approved for use in children or for type 1 diabetes.

  • Type 2 diabetes blood sugar control in adults

  • Used as an adjunct to diet and exercise

  • Can be combined with other diabetes medications

  • Not approved for pediatric patients or other conditions

Farxiga vs. Glimepiride Pros and Cons

Farxiga

Farxiga's broad set of FDA approvals means it can address heart failure and kidney disease risk at the same time as blood sugar control, which matters for many people with type 2 diabetes. It carries a higher price tag and specific genitourinary risks that glimepiride does not share.

Pros

  • FDA-approved for heart failure and chronic kidney disease, not just diabetes

  • Low risk of causing hypoglycemia when used alone

  • Approved for children 10 and older with type 2 diabetes

  • May promote modest weight loss

Cons

  • Roughly $400 to $785 per month without insurance, before savings programs

  • Risk of genital yeast infections and urinary tract infections

  • Carries a rare but serious Fournier's gangrene warning

  • Not recommended once kidney function drops below a certain level

Glimepiride

Glimepiride is a decades-old, inexpensive option that lowers blood sugar reliably, but it works only on glucose control and carries a meaningful risk of low blood sugar. It has no heart or kidney benefit and needs a slower dose increase to find an effective level.

Pros

  • Roughly $10 to $20 per month, one of the least expensive diabetes pills

  • Decades of clinical use and prescribing experience

  • Simple once-daily oral dosing after titration

  • Can be combined with metformin or insulin for added effect

Cons

  • Meaningful risk of hypoglycemia, especially with missed meals

  • No heart failure or kidney disease benefit

  • Requires gradual dose titration over several weeks

  • Possible link to increased cardiovascular mortality per older studies

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.